Literature DB >> 11892859

Benign breast disease.

Douglas J Marchant1.   

Abstract

This article describes 25 years of clinical experience in the setting of a Breast Health Center devoted to benign and malignant disease of the breast. During this period, more than 100,000 patients have been evaluated and treated for a wide variety of breast problems. This experience has provided an extraordinary opportunity to evaluate the natural history of benign breast disease and the frequent observation that the relevant medical literature does not reflect the entire spectrum of these conditions or the appropriate treatment. Most textbooks on breast disease emphasize breast cancer and the late manifestations of benign breast disease that often require surgical treatment. More than 180,000 cases of breast cancer occur each year in the United States. The number of women with benign breast disease is far greater and can be counted in the millions. For these patients, the well-trained primary care physician can provide appropriate evaluation and treatment, including appropriate recommendations for referral. For most patients with breast symptomatology, the goal is relief of symptoms and resolution of the problem. To accomplish this requires a contemporary knowledgebase combined with adequate time spent with the patient.

Entities:  

Mesh:

Year:  2002        PMID: 11892859     DOI: 10.1016/s0889-8545(03)00048-2

Source DB:  PubMed          Journal:  Obstet Gynecol Clin North Am        ISSN: 0889-8545            Impact factor:   2.844


  6 in total

1.  Selected Background Findings and Interpretation of Common Lesions in the Female Reproductive System in Macaques.

Authors:  J Mark Cline; Charles E Wood; Justin D Vidal; Ross P Tarara; Eberhard Buse; Gerhard F Weinbauer; Eveline P C T de Rijk; Eric van Esch
Journal:  Toxicol Pathol       Date:  2008-12       Impact factor: 1.902

2.  History of benign breast disease and risk of breast cancer among women in China: a case-control study.

Authors:  Tsogzolmaa Dorjgochoo; Sandra L Deming; Yu-Tang Gao; Wei Lu; Ying Zheng; Zhixian Ruan; Wei Zheng; Xiao Ou Shu
Journal:  Cancer Causes Control       Date:  2008-03-18       Impact factor: 2.506

3.  Therapeutic effects and mechanism of ferulic acid and icariin in mammary gland hyperplasia model rats via regulation of the ERK pathway.

Authors:  Xiang Li; Guobing Shi
Journal:  Ann Transl Med       Date:  2021-04

4.  Modulatory Effect of Fermented Papaya Extracts on Mammary Gland Hyperplasia Induced by Estrogen and Progestin in Female Rats.

Authors:  Zhenqiang You; Junying Sun; Feng Xie; Zhiqin Chen; Sheng Zhang; Hao Chen; Fang Liu; Lili Li; Guocan Chen; Yisheng Song; Yaoxian Xuan; Gaoli Zheng; Yanfei Xin
Journal:  Oxid Med Cell Longev       Date:  2017-11-20       Impact factor: 6.543

5.  Anti-Inflammatory Effect of a TCM Formula Li-Ru-Kang in Rats With Hyperplasia of Mammary Gland and the Underlying Biological Mechanisms.

Authors:  Yingying Wang; Shizhang Wei; Tian Gao; Yuxue Yang; Xiaohua Lu; Xuelin Zhou; Haotian Li; Tao Wang; Liqi Qian; Yanling Zhao; Wenjun Zou
Journal:  Front Pharmacol       Date:  2018-11-20       Impact factor: 5.810

6.  Mammotome® biopsy system for the resection of breast lesions: Clinical experience in two high-volume teaching hospitals.

Authors:  Yangping Jiang; Huanrong Lan; Qian Ye; Ketao Jin; Min Zhu; Xiaoyan Hu; Lisong Teng; Feilin Cao; Xianfang Lin
Journal:  Exp Ther Med       Date:  2013-07-01       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.